Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 204.36% | 206.44% | 9.41% | -9.37% | 0.34% |
| Total Depreciation and Amortization | -37.37% | -11.62% | 11.27% | -2.83% | 9.60% |
| Total Amortization of Deferred Charges | -45.30% | -72.86% | -62.01% | -61.54% | -53.20% |
| Total Other Non-Cash Items | -872.46% | -32,102.10% | -124.05% | -138.25% | -163.00% |
| Change in Net Operating Assets | 145.54% | 140.57% | -202.98% | -226.06% | -228.19% |
| Cash from Operations | 34.85% | 1.34% | -52.81% | -93.11% | -250.45% |
| Capital Expenditure | 83.02% | 72.65% | 53.13% | 20.52% | -22.59% |
| Sale of Property, Plant, and Equipment | 39,836.36% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 218.51% | 202.82% | 54.95% | 23.92% | -16.24% |
| Total Debt Issued | -96.13% | -93.48% | -55.91% | -75.57% | -- |
| Total Debt Repaid | 51.54% | 35.71% | -2.09% | -3.81% | -2.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.53% | -55.43% | -45.89% | -24.43% | -12.94% |
| Cash from Financing | -101.70% | -91.74% | -68.41% | -74.44% | 103.03% |
| Foreign Exchange rate Adjustments | -77.12% | 105.76% | 34.63% | 108.46% | 72.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.91% | -148.39% | -229.33% | -198.60% | 114.85% |